Rapport Therapeutics
Boston
About Rapport Therapeutics
Rapport Therapeutics operates as a clinical-stage biotechnology company, that discovers and develops precision medicines for neurological disorders. Rapport Therapeutics describes relationships that are defined by understanding, communication, teamwork, and trust.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Total funding: $500.0M
- Funding stage: IPO
- Last round: Post-IPO Equity (Sep 2025)
- Ticker: nasdaq:RAPP
- Website: rapportrx.com
- Phone: (857) 321-8020
Industries & Categories
Biotechnology, Health Care, Life Science, Medical, Neuroscience
Social Profiles
Canonical: https://fsome.com/organization/rapport-therapeutics-91907 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.